Long-term cenobamate retention, efficacy, and safety: outcomes from Expanded Access Programme

CONCLUSIONS AND CLINICAL IMPLICATIONS: Long-term effectiveness, including ≥ 50% seizure reduction and a 100% retention rate, was sustained over 41 months of CNB treatment within the Expanded Access Programme. No new safety issues were identified. These results provide support for the potential long-term clinical benefits of cenobamate.PMID:38112647 | DOI:10.5603/pjnns.97121

Source: Neurologia i Neurochirurgia Polska - December 19, 2023 Category: Neurology Authors: Anetta Lasek-Bal Barbara K ściuk Tomasz Zieli ński Agnieszka Krzak-Kubica Jacek Kowalski Barbara Żorniak-Milach Katarzyna Maciejowska Maciej Maciejowski Anna Wagner-Kusz Magdalena Bosak Source Type: research